Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2014; 20(2): 401-413
Published online Jan 14, 2014. doi: 10.3748/wjg.v20.i2.401
Figure 1
Figure 1 Progress in the field of hepatitis B virus. HBV: Hepatitis B virus; HBeAg: Hepatitis B e antigen; HCC: Hepatocellular carcinoma.
Figure 2
Figure 2 Five phases of chronic hepatitis B. Adapted from Tong et al[37]. ALT: Alanine aminotransferase; Anti-HBc: Hepatitis B core antibody; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; Anti-HBe: Hepatitis B e antibody.
Figure 3
Figure 3 Timeline of approved therapies for chronic hepatitis B. IFN: Interferon.
Figure 4
Figure 4 Characteristics of approved drugs for treatment of hepatitis B.